Matthews International Capital Management’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-261,000
Closed -$46.2M 53
2021
Q2
$46.2M Buy
261,000
+29,300
+13% +$4.71M 1.92% 15
2021
Q1
$30.9M Buy
231,700
+229,600
+10,933% +$35.5M 1.29% 19
2020
Q4
$284K Sell
2,100
-20,500
-91% -$2.09M 0.02% 40
2020
Q3
$1.88M Sell
22,600
-231,800
-91% -$18.6M 0.13% 25
2020
Q2
$20.9M Buy
254,400
+157,300
+162% +$10.6M 1.62% 18
2020
Q1
$5M Sell
97,100
-2,300
-2% -$120K 0.32% 27
2019
Q4
$4.13M Buy
99,400
+17,800
+22% +$657K 0.2% 29
2019
Q3
$2.64M Buy
81,600
+21,000
+35% +$720K 0.12% 31
2019
Q2
$2.11M Sell
60,600
-7,100
-10% -$209K 0.1% 33
2019
Q1
$2M Buy
67,700
+56,061
+482% +$1.53M 0.09% 32
2018
Q4
$270K Buy
+11,639
New +$216K 0.02% 34

Other funds holding ZLAB

Matthews International Capital Management's ZLAB Position: Q3 2021 in Review

Matthews International Capital Management sold out of Zai Lab (ZLAB) in Q3 2021, closing a stake of 261,000 shares — an estimated $46.2M sold.

Matthews International Capital Management first reported a position in ZLAB in Q4 2018 and held it in 11 quarters. The position peaked at $46.2M in Q2 2021. 227 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

  • Matthews International Capital Management reported no remaining Zai Lab position as of Q3 2021 after selling out during the quarter.
  • Matthews International Capital Management sold 261,000 Zai Lab shares in Q3 2021, an estimated $46.2M.
  • Matthews International Capital Management first reported a position in Zai Lab in Q4 2018 and held it in 11 quarters.
  • Matthews International Capital Management's Zai Lab position peaked at $46.2M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Matthews International Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.